ANIP
ANI PHARMACEUTICALS INC
ANI PHARMACEUTICALS INC (ANIP) has 16 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 21, 2026.
The most active filer is SR. VP, GENERAL COUNSEL & SEC. Cook Meredith with 3 filings. Insiders have net sold $6.7M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Nikhil Lalwani
- Employees:897
- HQ:Baudette, MN, US
- IPO:2000-05-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$1.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $41K | Jul 14 | SEC ↗ | |
| SVP & CFO | Sale | 3,313 | $285K | Jul 7 | SEC ↗ | |
| SVP & CFO | Sale | 2,850 | $240K | Jun 30 | SEC ↗ | |
| SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $41K | Jun 15 | SEC ↗ | |
HAUGHEY THOMASFirst filing | Director | Sale | 2,000 | $162K | Jun 11 | SEC ↗ |
CAREY STEPHEN P.First filing | SVP & CFO | Sale | 3,312 | $265K | Jun 9 | SEC ↗ |
Walsh Patrick DFirst filing | Director | Sale | 3,973 | $321K | May 14 | SEC ↗ |
Walsh Patrick DFirst filing | Director | Sale | 10,000 | $806K | May 14 | SEC ↗ |
Cook MeredithFirst filing | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $39K | May 13 | SEC ↗ |
Gutwerg OriFirst filing | SVP, GENERICS | Sale | 2,772 | $220K | May 13 | SEC ↗ |
Rowland Thomas AndrewFirst filing | SVP, HEAD - ESTABLISHED BRANDS | Sale | 459 | $36K | May 13 | SEC ↗ |
Lalwani NikhilFirst filing | PRESIDENT & CEO | Sale | 55,000 | $4.3M | May 13 | SEC ↗ |
Related companies
ANI PHARMACEUTICALS INC is in the Healthcare sector.